Healthcare -
Biotechnology - NASDAQ - US
$ 684.01
0.136 %
$ 73.9 B
Market Cap
16.93
P/E
REGN - TOTAL CURRENT ASSETS
Total Current Assets REGN - Regeneron Pharmaceuticals, Inc.
19.5 B
LAST VALUE
-2.57%
2 YEAR CAGR
19.60%
5 YEAR CAGR
24.08%
10 YEAR CAGR